Clinical Trial

The Cardiovascular-Renal-Metabolic (CRM) Syndrome Survey in Jordan

Study acronym: JoCRMSSurvey
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Cardiovascular-renal-metabolic (CRM) syndrome is defined as a systemic disorder with a collection of related signs and symptoms attributable to the coexistence of multiple cardiovascular, renal and metabolic disease with a common underlying pathophysiology in one individual. Surveying this syndrome in a large population in Jordan aims at studying the risk factors, components and stages of the syndrome, thus helping early screening, diagnosing and treating disease and its risk factors.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-05-09; most recent amendment 2025-12-22.
Trial Details
NCT Number NCT06413160
Lead Sponsor Jordan Collaborating Cardiology Group
Collaborators: Cardiovascular Academy, The Association of Jordanian Medical Laboratory Specialists AJMLS
Conditions Cardiovascular-renal-metabolic Syndrome
Enrollment 10,000 participants
Start Date 2026-07-01
Primary Completion 2027-08-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-12-30